Molecular subtypes of malignant peritoneal mesothelioma
Ontology highlight
ABSTRACT: Malignant Peritoneal Mesothelioma (PeM) is a rare but frequently fatal cancer that originates from the peritoneal lining of the abdomen. Standard treatment of PeM is limited to cytoreductive surgery and/or chemotherapy, and no targeted therapies for PeM yet exist. This study performs comprehensive integrative analysis of genome, transcriptome, and proteome of treatment-naïve PeM tumors with the aim of identifying mesothelioma-related molecular alterations and potentially identifying novel treatment strategies.
INSTRUMENT(S): LTQ Orbitrap Elite
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Mesothelium, Peritoneal Cavity
DISEASE(S): Peritoneal Mesothelioma
SUBMITTER: Raunak Shrestha
LAB HEAD: Dr. Stephane Le Bihan
PROVIDER: PXD008873 | Pride | 2018-12-11
REPOSITORIES: Pride
ACCESS DATA